Axsome Therapeutics Executives Buy and Sell Shares Amid Company's Financial Performance.

Axsome Therapeutics, Inc.[AXSM] disclosed that Chief Commercial Officer Maizel Ari acquired 7,500 shares at $70.73 per share on January 21, 2026, and subsequently sold 7,500 shares at $184.44 per share on the same day. Additionally, Chief Financial Officer Pizzie Nick purchased 12,000 shares at $3.5 per share on January 22, 2026, and subsequently sold 12,000 shares at $187.92 per share on the same day.